Clinical Study
Altered Functional Connectivity within and between Brain Modules in Absence Epilepsy: A Resting-State Functional Magnetic Resonance Imaging Study
Table 1
Clinical information collected from the AE patients.
| | ID | Age (years) | Gender | Epilepsy duration (year) | Epilepsy subtype | Medication history | Seizure frequency | Medication after this test |
| | 1 | 12 | F | 5 | AE | None | 1-2/day | Lamotrigine | | 2 | 37 | F | 13 | AE + GTCS | Carbamazepine | 2-3/month | Levetiracetam | | 3 | 13 | M | 0a | AE | None | 1-2/month | Valproate | | 4 | 10 | M | 4 | AE + GTCS | Valproate | 10/day | Valproate | | 5 | 8 | F | 0b | AE | None | 4/year | Lamotrigine | | 6 | 25 | F | 5 | AE + GTCS | Carbamazepine | 1-2/month | Lamotrigine | | 7 | 14 | M | 2 | AE + GTCS | Carbamazepine | 1-2/month | Lamotrigine | | 8 | 40 | F | 7 | AE + GTCS | None | 2/year | Lamotrigine | | 9 | 20 | M | 6 | AE + GTCS | Carbamazepine | 1-2/day | Lamotrigine | | 10 | 21 | F | 13 | AE | None | 3–5/day | Lamotrigine | | 11 | 27 | F | 3 | AE | None | 2-3/week | Valproate | | 12 | 13 | M | 0a | AE + myoclonus | None | 10/day | Levetiracetam |
|
|
3 months, b7 months.
|
